Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis.

Laplaud DA, Casey R, Barbin L, Debouverie M, De Sèze J, Brassat D, Wiertlewski S, Brochet B, Pelletier J, Vermersch P, Edan G, Lebrun-Frenay C, Clavelou P, Thouvenot E, Camdessanché JP, Tourbah A, Stankoff B, Al Khedr A, Cabre P, Lubetzki C, Papeix C, Berger E, Heinzlef O, Debroucker T, Moreau T, Gout O, Bourre B, Wahab A, Labauge P, Magy L, Defer G, Guennoc AM, Maubeuge N, Labeyrie C, Patry I, Nifle C, Casez O, Michel L, Rollot F, Leray E, Vukusic S, Foucher Y; SFSEP and OFSEP groups.

Neurology. 2019 Aug 13;93(7):e635-e646. doi: 10.1212/WNL.0000000000007938. Epub 2019 Jul 12.

PMID:
31300547
2.

Fulminant and fatal onset of pan-aquaporinopathy.

Bonnan M, Mejdoubi M, Cabre P.

Mult Scler Relat Disord. 2019 Jun 24;34:116-118. doi: 10.1016/j.msard.2019.06.029. [Epub ahead of print]

PMID:
31255987
3.

Large brain cavitation revealing neuromyelitis optica. Neuroimage.

Bonnan M, Berthelot E, Cabre P.

Rev Neurol (Paris). 2019 Jun 17. pii: S0035-3787(19)30009-8. doi: 10.1016/j.neurol.2019.04.005. [Epub ahead of print] No abstract available.

PMID:
31221417
4.

Fingolimod for the treatment of multiple sclerosis in French West Indies, a real-world study in patients from African ancestry.

de Roquemaurel A, Galli P, Landais A, Avendano S, Cabre P.

J Neurol Sci. 2019 Jul 15;402:180-187. doi: 10.1016/j.jns.2019.05.027. Epub 2019 May 24.

PMID:
31158557
5.

Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders.

Palace J, Lin DY, Zeng D, Majed M, Elsone L, Hamid S, Messina S, Misu T, Sagen J, Whittam D, Takai Y, Leite MI, Weinshenker B, Cabre P, Jacob A, Nakashima I, Fujihara K, Pittock SJ.

Brain. 2019 May 1;142(5):1310-1323. doi: 10.1093/brain/awz054.

6.

Oligoclonal bands increase the specificity of MRI criteria to predict multiple sclerosis in children with radiologically isolated syndrome.

Makhani N, Lebrun C, Siva A, Narula S, Wassmer E, Brassat D, Brenton JN, Cabre P, Carra Dallière C, de Seze J, Durand Dubief F, Inglese M, Langille M, Mathey G, Neuteboom RF, Pelletier J, Pohl D, Reich DS, Ignacio Rojas J, Shabanova V, Shapiro ED, Stone RT, Tenembaum S, Tintoré M, Uygunoglu U, Vargas W, Venkateswaren S, Vermersch P, Kantarci O, Okuda DT, Pelletier D; Observatoire Francophone de la Sclérose en Plaques (OFSEP), Société Francophone de la Sclérose en Plaques (SFSEP), the Radiologically Isolated Syndrome Consortium (RISC) and the Pediatric Radiologically Isolated Syndrome Consortium (PARIS).

Mult Scler J Exp Transl Clin. 2019 Mar 20;5(1):2055217319836664. doi: 10.1177/2055217319836664. eCollection 2019 Jan-Mar.

7.

Predictive value of conventional MRI parameters in first spinal attacks of neuromyelitis optica spectrum disorder.

Bonnan M, Debeugny S, Mejdoubi M, Cabre P.

Mult Scler. 2019 Mar 7:1352458519834857. doi: 10.1177/1352458519834857. [Epub ahead of print]

PMID:
30843448
8.

Temporal trends in Human T-Lymphotropic virus 1 (HTLV-1) associated myelopathy/tropical spastic paraparesis (HAM/TSP) incidence in Martinique over 25 years (1986-2010).

Olindo S, Jeannin S, Saint-Vil M, Signate A, Edimonana-Kaptue M, Joux J, Merle H, Richard P, Granjeaud S, Cabre P, Smadja D, Cesaire R, Lezin A.

PLoS Negl Trop Dis. 2018 Mar 19;12(3):e0006304. doi: 10.1371/journal.pntd.0006304. eCollection 2018 Mar.

9.

Treatment of neuromyelitis optica with rituximab: a 2-year prospective multicenter study.

Cabre P, Mejdoubi M, Jeannin S, Merle H, Plumelle Y, Cavillon G, Smadja D, Marignier R; Francophone Society of Multiple Sclerosis and OFSEP investigators.

J Neurol. 2018 Apr;265(4):917-925. doi: 10.1007/s00415-018-8771-5. Epub 2018 Feb 17.

PMID:
29455361
10.

Meningeal and vestibulocochlear nerve enhancement in neuromyelitis optica.

Bonnan M, Cabre P.

Eur J Neurol. 2017 Dec;24(12):e89-e90. doi: 10.1111/ene.13453. No abstract available.

PMID:
29148221
11.

Treating asymptomatic bacteriuria before immunosuppressive therapy during multiple sclerosis: Should we do it?

Rouzaud C, Hautecoeur P, Donze C, Heinzlef O, Dinh A; Club Francophone de la Sclérose en Plaque, Creange A, Abdullatif A, Audouin B, Tourbah A, Berger E, Bourre B, Brochet B, Mekies C, Cabre P, Papeix C, Casez O, Brassat D, Defer G, Derache N, De Seze J, Dive D, LePage E, Fromont A, Gouider R, Edan G, Pelletier J, Grimaud J, Guennoc AM, Camdessanché JP, Kwiatkowski A, Laplaud D, Lebrun C, Debouverie M, Coustans M, Gout O, La Rochelle OA, Heinzlef O, Ouallet JC, Cavelou P, Hautecoeur P, Labauge P, Vermersch P, Wiertlewski S, Vukusic S, Marignier R, Schluep M, Seeldrayers P, Slassi I, Stankoff B, Thaite F, Moreau T, Thouvenot E, Zephir H, Ciron J, Collongues N, Kerschen P, Cohen M, Gueguen A, Mathey G, Carra C, Bernady P, Faucheux JM, Planque E, Donze C, Ruet A, Mouzawakh C, Pittion S.

Mult Scler Relat Disord. 2017 Nov;18:161-163. doi: 10.1016/j.msard.2017.08.009. Epub 2017 Aug 24. No abstract available.

PMID:
29141801
12.

Short delay to initiate plasma exchange is the strongest predictor of outcome in severe attacks of NMO spectrum disorders.

Bonnan M, Valentino R, Debeugny S, Merle H, Fergé JL, Mehdaoui H, Cabre P.

J Neurol Neurosurg Psychiatry. 2018 Apr;89(4):346-351. doi: 10.1136/jnnp-2017-316286. Epub 2017 Oct 13.

PMID:
29030418
13.

Retinal Nerve Fiber Layer Thickness in Human T-cell Lymphotropic Virus Type 1 Patients.

Merle H, Hage R, Jeannin S, Cabre P, Olindo S.

Curr Eye Res. 2017 Dec;42(12):1644-1649. doi: 10.1080/02713683.2017.1329443. Epub 2017 Oct 6.

PMID:
28985098
14.

One-year disability, death and recurrence after first-ever stroke in a Black Afro-Caribbean population.

Olindo S, Saint-Vil M, Jeannin S, Signate A, Edimonana-Kaptue M, Cabre P, Chausson N, Smadja D, Joux J.

Int J Stroke. 2017 Oct;12(8):844-850. doi: 10.1177/1747493016685720. Epub 2017 Jan 3.

PMID:
28043214
15.

Blood products use in France: a nationwide cross-sectional survey.

Fillet AM, Desmarets M, Assari S, Quaranta JF, François A, Pugin A, Schuhmacher A, Lassale B, Monnet E, Cabre P, Legrand D, Binda D, Djoudi R.

Transfusion. 2016 Dec;56(12):3033-3041. doi: 10.1111/trf.13887. Epub 2016 Nov 2.

PMID:
27807857
16.

Efficacy and safety profile of memantine in patients with cognitive impairment in multiple sclerosis: A randomized, placebo-controlled study.

Peyro Saint Paul L, Creveuil C, Heinzlef O, De Seze J, Vermersch P, Castelnovo G, Cabre P, Debouverie M, Brochet B, Dupuy B, Lebiez P, Sartori É, Clavelou P, Brassat D, Lebrun-Frenay C, Daplaud D, Pelletier J, Coman I, Hautecoeur P, Tourbah A, Defer G.

J Neurol Sci. 2016 Apr 15;363:69-76. doi: 10.1016/j.jns.2016.02.012. Epub 2016 Feb 6.

PMID:
27000224
17.

Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum.

Flanagan EP, Cabre P, Weinshenker BG, Sauver JS, Jacobson DJ, Majed M, Lennon VA, Lucchinetti CF, McKeon A, Matiello M, Kale N, Wingerchuk DM, Mandrekar J, Sagen JA, Fryer JP, Robinson AB, Pittock SJ.

Ann Neurol. 2016 May;79(5):775-783. doi: 10.1002/ana.24617. Epub 2016 Apr 4.

18.

Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study.

Barbin L, Rousseau C, Jousset N, Casey R, Debouverie M, Vukusic S, De Sèze J, Brassat D, Wiertlewski S, Brochet B, Pelletier J, Vermersch P, Edan G, Lebrun-Frenay C, Clavelou P, Thouvenot E, Camdessanché JP, Tourbah A, Stankoff B, Al Khedr A, Cabre P, Papeix C, Berger E, Heinzlef O, Debroucker T, Moreau T, Gout O, Bourre B, Créange A, Labauge P, Magy L, Defer G, Foucher Y, Laplaud DA; CFSEP and OFSEP groups.

Neurology. 2016 Feb 23;86(8):771-8. doi: 10.1212/WNL.0000000000002395. Epub 2016 Jan 29.

19.

Improvement to baseline after plasma exchange in spinal attacks associated with neuromyelitis optica.

Bonnan M, Cabre P.

Mult Scler J Exp Transl Clin. 2015 Dec 24;1:2055217315622794. doi: 10.1177/2055217315622794. eCollection 2015 Jan-Dec. No abstract available.

20.

Update on biomarkers in neuromyelitis optica.

Melamed E, Levy M, Waters PJ, Sato DK, Bennett JL, John GR, Hooper DC, Saiz A, Bar-Or A, Kim HJ, Pandit L, Leite MI, Asgari N, Kissani N, Hintzen R, Marignier R, Jarius S, Marcelletti J, Smith TJ, Yeaman MR, Han MH, Aktas O, Apiwattanakul M, Banwell B, Bichuetti D, Broadley S, Cabre P, Chitnis T, De Seze J, Fujihara K, Greenberg B, Hellwig K, Iorio R, Jarius S, Klawiter E, Kleiter I, Lana-Peixoto M, Nakashima, O'Connor K, Palace J, Paul F, Prayoonwiwat N, Ruprecht K, Stuve O, Tedder T, Tenembaum S, Garrahan JP, Aires B, van Herle K, van Pelt D, Villoslada P, Waubant E, Weinshenker B, Wingerchuk D, Würfel J, Zamvil S.

Neurol Neuroimmunol Neuroinflamm. 2015 Jul 23;2(4):e134. doi: 10.1212/NXI.0000000000000134. eCollection 2015 Aug. Review.

21.

Excess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational Study.

Leray E, Vukusic S, Debouverie M, Clanet M, Brochet B, de Sèze J, Zéphir H, Defer G, Lebrun-Frenay C, Moreau T, Clavelou P, Pelletier J, Berger E, Cabre P, Camdessanché JP, Kalson-Ray S, Confavreux C, Edan G.

PLoS One. 2015 Jul 6;10(7):e0132033. doi: 10.1371/journal.pone.0132033. eCollection 2015.

22.

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.

Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, de Seze J, Fujihara K, Greenberg B, Jacob A, Jarius S, Lana-Peixoto M, Levy M, Simon JH, Tenembaum S, Traboulsee AL, Waters P, Wellik KE, Weinshenker BG; International Panel for NMO Diagnosis.

Neurology. 2015 Jul 14;85(2):177-89. doi: 10.1212/WNL.0000000000001729. Epub 2015 Jun 19.

23.

Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder.

Kremer S, Renard F, Achard S, Lana-Peixoto MA, Palace J, Asgari N, Klawiter EC, Tenembaum SN, Banwell B, Greenberg BM, Bennett JL, Levy M, Villoslada P, Saiz A, Fujihara K, Chan KH, Schippling S, Paul F, Kim HJ, de Seze J, Wuerfel JT; Guthy-Jackson Charitable Foundation (GJCF) Neuromyelitis Optica (NMO) International Clinical Consortium and Biorepository, Cabre P, Marignier R, Tedder T, van Pelt D, Broadley S, Chitnis T, Wingerchuk D, Pandit L, Leite MI, Apiwattanakul M, Kleiter I, Prayoonwiwat N, Han M, Hellwig K, van Herle K, John G, Hooper DC, Nakashima I, Sato D, Yeaman MR, Waubant E, Zamvil S, Stüve O, Aktas O, Smith TJ, Jacob A, O'Connor K.

JAMA Neurol. 2015 Jul;72(7):815-22. doi: 10.1001/jamaneurol.2015.0248. Review.

24.

Isolated tumefactive demyelinating lesions: diagnosis and long-term evolution of 16 patients in a multicentric study.

Siri A, Carra-Dalliere C, Ayrignac X, Pelletier J, Audoin B, Pittion-Vouyovitch S, Debouverie M, Lionnet C, Viala F, Sablot D, Brassat D, Ouallet JC, Ruet A, Brochet B, Taillandier L, Bauchet L, Derache N, Defer G, Cabre P, de Seze J, Lebrun Frenay C, Cohen M, Labauge P.

J Neurol. 2015 Jul;262(7):1637-45. doi: 10.1007/s00415-015-7758-8. Epub 2015 May 1.

PMID:
25929666
25.

Trends in incidence and early outcomes in a Black Afro-Caribbean population from 1999 to 2012: Etude Réalisée en Martinique et Centrée sur l'Incidence des Accidents Vasculaires Cérébraux II Study.

Olindo S, Chausson N, Mejdoubi M, Jeannin S, Rosillette K, Saint-Vil M, Signate A, Edimonana-Kaptue M, Larraillet V, Cabre P, Smadja D, Joux J.

Stroke. 2014 Nov;45(11):3367-73. doi: 10.1161/STROKEAHA.114.005930. Epub 2014 Sep 11.

PMID:
25213341
26.

Infarction in the anterior choroidal artery territory: clinical progression and prognosis factors.

Chausson N, Joux J, Saint-Vil M, Edimonana M, Jeannin S, Aveillan M, Cabre P, Olindo S, Smadja D.

J Stroke Cerebrovasc Dis. 2014 Sep;23(8):2012-2017. doi: 10.1016/j.jstrokecerebrovasdis.2014.02.013. Epub 2014 Aug 1.

PMID:
25088169
27.

Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative study.

Brickshawana A, Hinson SR, Romero MF, Lucchinetti CF, Guo Y, Buttmann M, McKeon A, Pittock SJ, Chang MH, Chen AP, Kryzer TJ, Fryer JP, Jenkins SM, Cabre P, Lennon VA.

Lancet Neurol. 2014 Aug;13(8):795-806. doi: 10.1016/S1474-4422(14)70141-3. Epub 2014 Jul 6.

28.

No evidence for genetic association between glutamate transporter EAAT2 and Devic's neuromyelitis optica in caucasians and afro-caribbeans.

Hanoux V, Coulbault L, Derache N, Cabre P, De Seze J, Marignier R, Rudolf G, Emmanuelle Dugué A, Allouche S, Defer G; NOMADMUS Study Group.

Mult Scler Relat Disord. 2014 Jan;3(1):89-93. doi: 10.1016/j.msard.2013.06.012. Epub 2013 Jul 18.

PMID:
25877978
29.

Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients.

Kremer L, Mealy M, Jacob A, Nakashima I, Cabre P, Bigi S, Paul F, Jarius S, Aktas O, Elsone L, Mutch K, Levy M, Takai Y, Collongues N, Banwell B, Fujihara K, de Seze J.

Mult Scler. 2014 Jun;20(7):843-7. doi: 10.1177/1352458513507822. Epub 2013 Oct 7.

PMID:
24099751
30.

A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort.

Outteryck O, Ongagna JC, Brochet B, Rumbach L, Lebrun-Frenay C, Debouverie M, Zéphir H, Ouallet JC, Berger E, Cohen M, Pittion S, Laplaud D, Wiertlewski S, Cabre P, Pelletier J, Rico A, Defer G, Derache N, Camu W, Thouvenot E, Moreau T, Fromont A, Tourbah A, Labauge P, Castelnovo G, Clavelou P, Casez O, Hautecoeur P, Papeix C, Lubetzki C, Fontaine B, Couturier N, Bohossian N, Clanet M, Vermersch P, de Sèze J, Brassat D; BIONAT Network,; CFSEP.

Eur J Neurol. 2014;21(1):40-8. doi: 10.1111/ene.12204. Epub 2013 Jun 12.

PMID:
23895407
31.

Visual field characteristics in neuromyelitis optica in absence of and after one episode of optic neuritis.

Merle H, Olindo S, Jeannin S, Hage R, Donnio A, Richer R, Cabre P.

Clin Ophthalmol. 2013;7:1145-53. doi: 10.2147/OPTH.S43894. Epub 2013 Jun 11.

32.

Prehospital transfer medicalization increases thrombolysis rate in acute ischemic stroke. A French stroke unit experience.

Joux J, Olindo S, Girard-Claudon A, Chausson N, Saint-Vil M, Signate A, Edimonana M, Jeannin S, Aveillan M, Cabre P, Smadja D.

Clin Neurol Neurosurg. 2013 Sep;115(9):1583-5. doi: 10.1016/j.clineuro.2013.02.010. Epub 2013 Mar 13.

PMID:
23489443
33.

Efficacy of mitoxantrone in neuromyelitis optica spectrum: clinical and neuroradiological study.

Cabre P, Olindo S, Marignier R, Jeannin S, Merle H, Smadja D; Aegis of French National Observatory of Multiple Sclerosis.

J Neurol Neurosurg Psychiatry. 2013 May;84(5):511-6. doi: 10.1136/jnnp-2012-303121. Epub 2012 Nov 8.

PMID:
23138769
34.

Fluid-attenuated inversion recovery vascular hyperintensity: an early predictor of clinical outcome in proximal middle cerebral artery occlusion.

Olindo S, Chausson N, Joux J, Saint - Vil M, Signate A, Edimonana-Kapute M, Jeannine S, Mejdoubi M, Aveillan M, Cabre P, Smadja D.

Arch Neurol. 2012 Nov;69(11):1462-8.

PMID:
22893218
35.

Treatment of optic neuritis by plasma exchange (add-on) in neuromyelitis optica.

Merle H, Olindo S, Jeannin S, Valentino R, Mehdaoui H, Cabot F, Donnio A, Hage R, Richer R, Smadja D, Cabre P.

Arch Ophthalmol. 2012 Jul;130(7):858-62. doi: 10.1001/archophthalmol.2012.1126.

PMID:
22776923
36.

Plasma exchange in severe attacks of neuromyelitis optica.

Bonnan M, Cabre P.

Mult Scler Int. 2012;2012:787630. doi: 10.1155/2012/787630. Epub 2012 Feb 12.

37.

A case of late-onset multiple sclerosis mimicking glioblastoma and displaying intraoperative 5-aminolevulinic acid fluorescence.

Nestler U, Warter A, Cabre P, Manzo N.

Acta Neurochir (Wien). 2012 May;154(5):899-901. doi: 10.1007/s00701-012-1319-z. Epub 2012 Mar 9. No abstract available.

38.

Response to interferon-Beta treatment in afro-caribbeans with multiple sclerosis.

Jeannin S, Deschamps R, Chausson N, Cabre P.

Mult Scler Int. 2011;2011:950126. doi: 10.1155/2011/950126. Epub 2011 May 23.

39.

A benign form of neuromyelitis optica: does it exist?

Collongues N, Cabre P, Marignier R, Zéphir H, Papeix C, Audoin B, Lebrun-Frenay C, Pelletier J, Fontaine B, Vermersch P, Confavreux C, de Seze J; Group Members for NOMADMUS and CF-SEP.

Arch Neurol. 2011 Jul;68(7):918-24. doi: 10.1001/archneurol.2011.127.

PMID:
21747032
40.

Anatomic and functional correlation of frequency-doubling technology perimetry (FDTP) in multiple sclerosis.

Merle H, Olindo S, Donnio A, Richer R, Smadja D, Cabre P.

Int Ophthalmol. 2011 Aug;31(4):263-70. doi: 10.1007/s10792-011-9447-7. Epub 2011 Jun 3.

PMID:
21637977
41.

Ocular oscillations in the neuromyelitis optica spectrum.

Hage R Jr, Merle H, Jeannin S, Cabre P.

J Neuroophthalmol. 2011 Sep;31(3):255-9. doi: 10.1097/WNO.0b013e31821d549b.

PMID:
21623230
42.

A new therapeutic strategy for acute ischemic stroke: sequential combined intravenous tPA-tenecteplase for proximal middle cerebral artery occlusion based on first results in 13 consecutive patients.

Smadja D, Chausson N, Joux J, Saint-Vil M, Signaté A, Edimonana M, Jeannin S, Bartoli B, Aveillan M, Cabre P, Olindo S.

Stroke. 2011 Jun;42(6):1644-7. doi: 10.1161/STROKEAHA.110.610147. Epub 2011 Apr 28.

PMID:
21527758
43.

Different HLA class II (DRB1 and DQB1) alleles determine either susceptibility or resistance to NMO and multiple sclerosis among the French Afro-Caribbean population.

Deschamps R, Paturel L, Jeannin S, Chausson N, Olindo S, Béra O, Bellance R, Smadja D, Césaire D, Cabre P.

Mult Scler. 2011 Jan;17(1):24-31. doi: 10.1177/1352458510382810. Epub 2010 Sep 22.

PMID:
20861181
44.

Absence of consistent association between human leukocyte antigen-I and -II alleles and human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis risk in an HTLV-1 French Afro-Caribbean population.

Deschamps R, Béra O, Belrose G, Lezin A, Bellance R, Signate A, Cabre P, Smadja D, Césaire R, Olindo S.

Int J Infect Dis. 2010 Nov;14(11):e986-90. doi: 10.1016/j.ijid.2010.05.020. Epub 2010 Sep 17.

45.

Association between basilar artery hypoplasia and undetermined or lacunar posterior circulation ischemic stroke.

Olindo S, Khaddam S, Bocquet J, Chausson N, Aveillan M, Cabre P, Smadja D.

Stroke. 2010 Oct;41(10):2371-4. doi: 10.1161/STROKEAHA.110.593145. Epub 2010 Aug 26.

PMID:
20798365
46.

Neuromyelitis optica associated with subacute human T-lymphotropic virus type 1 infection.

Olindo S, Bonnan M, Merle H, Signate A, Smadja D, Cabre P.

J Clin Neurosci. 2010 Nov;17(11):1449-51. doi: 10.1016/j.jocn.2009.12.024. Epub 2010 Jul 17.

PMID:
20638847
47.

Multiple sclerosis and solar exposure before the age of 15 years: case-control study in Cuba, Martinique and Sicily.

Dalmay F, Bhalla D, Nicoletti A, Cabrera-Gomez JA, Cabre P, Ruiz F, Druet-Cabanac M, Dumas M, Preux PM.

Mult Scler. 2010 Aug;16(8):899-908. doi: 10.1177/1352458510366856. Epub 2010 May 12.

PMID:
20463038
48.

Five-year outcome of a stroke cohort in Martinique, French West Indies: Etude Réalisée en Martinique et Centrée sur l'Incidence des Accidents vasculaires cérebraux, Part 2.

Chausson N, Olindo S, Cabre P, Saint-Vil M, Smadja D.

Stroke. 2010 Apr;41(4):594-9. doi: 10.1161/STROKEAHA.109.573402. Epub 2010 Feb 18.

PMID:
20167913
49.

Retinal nerve fiber layer thickness and spatial and temporal contrast sensitivity in multiple sclerosis.

Merle H, Olindo S, Donnio A, Beral L, Richer R, Smadja D, Cabre P.

Eur J Ophthalmol. 2010 Jan-Feb;20(1):158-66.

PMID:
19882537
50.

Relapsing neuromyelitis optica: long term history and clinical predictors of death.

Cabre P, González-Quevedo A, Bonnan M, Saiz A, Olindo S, Graus F, Smadja D, Merle H, Thomas L, Cabrera-Gomez JA.

J Neurol Neurosurg Psychiatry. 2009 Oct;80(10):1162-4. doi: 10.1136/jnnp.2007.143529.

PMID:
19762908

Supplemental Content

Support Center